Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study

Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study

Objective: To examine the association between plasma levels of the soluble urokinase plasminogen activator receptor (suPAR) and the incidence of severe complications of COVID-19. Methods: 403 RT-PCR-confirmed COVID-19 patients were recruited and prospectively followed-up at a major hospital in the U...

Full description

Bibliographic Details
Main Authors: Abderrahim Oulhaj, Ahmed R. Alsuwaidi, Abubaker Suliman, Huda Gasmelseed, Shaima Khan, Shamma Alawi, Yaman Hukan, Junu George, Fayez Alshamsi, Farrukh Sheikh, Zahir Osman Eltahir Babiker, Juergen Prattes, Harald Sourij
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
Urokinase plasminogen activator
Acute respiratory distress syndrome
Intensive care admission
All-cause mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221003374

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221003374

Similar Items